MM
Marc Rubin, M.D.
Director, GALECTIN THERAPEUTICS INC
- Source reported. 1 of 12 claims corroborated by a second source.
- Not claimed. Is this you?
- Eval: not assessed.
Board service
7 claims| Fact | Stated value | Valid from | Evidence |
|---|---|---|---|
| Professional role | Director at GALECTIN THERAPEUTICS INC | Source reportedE4 | |
| Professional role | Director at CURIS INC | Source reportedE1 | |
| Board membership | Serves on the board of CURIS INC | Source reportedE6 | |
| Board membership | Serves on the board of GALECTIN THERAPEUTICS INC | Source reportedE5 | |
| Board role | Director | CorroboratedE2E3 | |
| Committee assignments | Audit, Compensation | Source reportedE2 | |
| Committee assignments | Nominating/Governance | Source reportedE3 |
AI, cyber, technology
2 claims| Fact | Stated value | Evidence |
|---|---|---|
| AI and ML experience | Not identified in the cited filing | Source reportedE3 |
| Technology background | Not identified in the cited filing | Source reportedE3 |
Other published claims
3 claims| Fact | Stated value | Evidence |
|---|---|---|
| Cybersecurity experience | Not identified in the cited filing | Source reportedE3 |
| Executive company | Executive at Titan Pharmaceuticals, Inc. | Source reportedE3 |
| Executive title | Executive Chairman | Source reportedE3 |
Evidence
6 evidence records| Ref | Source | Authority | Source date | Retrieved | Rights | Cited by |
|---|---|---|---|---|---|---|
| E1 | Source title not publishedSEC form ownership | Authoritative, regulatory filing | Rights not recorded, link only | 1 claim | ||
| E2 | CRIS DEF 14A director slateSEC EDGAR. SEC filing | Authoritative, regulatory filing | Rights not recorded, link only | 2 claims | ||
| E3 | GALT DEF 14A director slateSEC EDGAR. SEC filing | Authoritative, regulatory filing | Rights not recorded, link only | 7 claims | ||
| E4 | Source title not publishedSEC proxy | Authoritative, regulatory filing | Rights not recorded, link only | 1 claim | ||
| E5 | Source title not publishedPublic source | Authoritative, regulatory filing | Not recorded | Not recorded | Rights not recorded, link only | 1 claim |
| E6 | Source title not publishedPublic source | Authoritative, regulatory filing | Not recorded | Not recorded | Rights not recorded, link only | 1 claim |
No evidence record is pinned or signed yet.
Not yet in this record
These parts of a person record have no published claims yet. That is a coverage state, not a finding about the person.
- Committees
- Work experience
- Education and credentials
- Compensation
- Conflicts and accountability
Limits of this record (4)
- Only permissioned public claims and evidence are included.
- Absence of a claim is not evidence that the underlying fact is false.
- Public retrieval does not grant model-training or redistribution rights.
- Private relationships and Council activity are excluded.
History
Version public-0Published .
- Director appointed. Marc Rubin, M.D. seat on GALECTIN THERAPEUTICS INC, effective 2011.Effective . Recorded .
About this record
- Alpha ID
- alpha:person:marc-rubin-m-d
- Version
- public-0:d751713988987e9331980363e24189ce
- Identity
- Not claimed
- Evidence
- Corroborated in part
- Evaluation
- Not assessed
- Monitoring
- Not monitored yet
- Authority
- Not published
- Freshness
- Current
- Integrity
- Not signed yet
- Basis
- Public role at an organization in the published Registry
- Never published
- Home address, family, personal contacts, health, and history unrelated to the public role
The subject can claim this record and correct or dispute any claim. Corrections are versioned and the original stays in history. A subject's own statements are shown as subject attested and never replace the cited evidence.

